{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:32:20Z","timestamp":1787506340472,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phymed.2025.157315","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:54:02Z","timestamp":1758700442000},"page":"157315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7740-9005","authenticated-orcid":false,"given":"Yuerong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasa","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunru","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"04","key":"10.1016\/j.phymed.2025.157315_bib0001","first-page":"323","article-title":"Protective effect and mechanism of Songling Xuemaikang Capsule on vascular endothelial injury induced by chronic intermittent hypoxia in hypertensive mice","volume":"38","author":"Ai","year":"2022","journal-title":"Chin J Clin Pharmacol"},{"issue":"10285","key":"10.1016\/j.phymed.2025.157315_bib0002","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.phymed.2025.157315_bib0003","first-page":"1149","article-title":"Ambulatory blood pressure monitoring for the hypotensive effect of Songling Xuemaikang Capsule","author":"Chen","year":"2002","journal-title":"Sichuan Med J"},{"issue":"09","key":"10.1016\/j.phymed.2025.157315_bib0004","first-page":"1055","article-title":"Effects of different antihypertensive regimens combined with Song ling xue mai kang capsule on antihypertensive effect","volume":"11","author":"Dong","year":"2013","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"issue":"06","key":"10.1016\/j.phymed.2025.157315_bib0005","first-page":"1042","article-title":"Serum pharmacochemistry of Songling Xuemaikang capsules: based on UPLC-MS\/MS","volume":"24","author":"Hao","year":"2022","journal-title":"Mod Chin Med"},{"issue":"1","key":"10.1016\/j.phymed.2025.157315_bib0006","first-page":"8867","article-title":"Bioactivity-guided fractionation of pine needle reveals Catechin as an anti-hypertension agent via","volume":"7","author":"He","year":"2017","journal-title":"Inhib. Angiotensin-Convert. Enzyme. Sci Rep"},{"issue":"10380","key":"10.1016\/j.phymed.2025.157315_bib0007","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.phymed.2025.157315_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMa"},{"issue":"1","key":"10.1016\/j.phymed.2025.157315_bib0009","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13063-019-3308-5","article-title":"Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial","volume":"20","author":"Jiang","year":"2019","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.phymed.2025.157315_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007923","article-title":"Efficacy and safety of Chinese herbal medicine compared with Losartan for mild essential hypertension: a randomized, multicenter, double-blind, noninferiority trial","volume":"15","author":"Lai","year":"2022","journal-title":"Circ. Cardiovasc. Qual. Outcomes."},{"issue":"03","key":"10.1016\/j.phymed.2025.157315_bib0011","first-page":"160","article-title":"Mechanism of Songling Xuemaikang capsule on renal hypertension in rats with liver Yang hyperactivity","volume":"31","author":"Li","year":"2014","journal-title":"Tianjin J Tradit Chin Med"},{"issue":"1","key":"10.1016\/j.phymed.2025.157315_bib0012","first-page":"488","article-title":"Isolariciresinol-9\u2032-O-\u03b1-l-arabinofuranoside protects against hydrogen peroxide\u2011induced apoptosis of human umbilical vein endothelial cells via a PI3K\/Akt\/bad\u2011dependent pathway","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"03","key":"10.1016\/j.phymed.2025.157315_bib0013","first-page":"259","article-title":"Protective effect of Songling Xuemaikang capsule on oxidative injury of human umbilical vein endothelial cells","volume":"33","author":"Liu","year":"2018","journal-title":"WCJPS"},{"issue":"1","key":"10.1016\/j.phymed.2025.157315_bib0014","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12906-025-05038-y","article-title":"The effects of Songling Xuemaikang capsule on vascular remodeling of stage 1 hypertension: a multicenter, randomized placebo-controlled trial protocol","volume":"25","author":"Liu","year":"2025","journal-title":"BMC. Complement. Med. Ther."},{"issue":"04","key":"10.1016\/j.phymed.2025.157315_bib0015","first-page":"1322","article-title":"Regulatory mechanism of Songling Xuemaikang Capsule on RAAS system in spontaneously hypertensive rats","volume":"30","author":"Liu","year":"2015","journal-title":"CJTCMP"},{"key":"10.1016\/j.phymed.2025.157315_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153915","article-title":"Puerarin action on stem cell proliferation, differentiation and apoptosis: therapeutic implications for geriatric diseases","volume":"96","author":"Ma","year":"2022","journal-title":"Phytomedicine"},{"issue":"38","key":"10.1016\/j.phymed.2025.157315_bib0017","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.phymed.2025.157315_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154459","article-title":"Efficacy and safety of Songling Xuemaikang capsule for essential hypertension: a systematic review and meta-analysis of randomized controlled trials","volume":"107","author":"Meng","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157315_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112660","article-title":"Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKII\u03b4 and ERK1\/2 pathways","volume":"253","author":"Qi","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"19","key":"10.1016\/j.phymed.2025.157315_bib0020","first-page":"5375","article-title":"Evidence mapping of clinical research on prevention and treatment of essential hypertension with Chinese patent medicines in recent six years","volume":"47","author":"Qiao","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"issue":"05","key":"10.1016\/j.phymed.2025.157315_bib0021","article-title":"Effects of Songling Xuemai Kang capsule on the expression of hypertension related genes in spontaneously hypertensive rats","volume":"23","author":"Shi","year":"2017","journal-title":"J Basic Chin Med"},{"issue":"1","key":"10.1016\/j.phymed.2025.157315_bib0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1142\/S0192415X19500022","article-title":"Puerarin reduces blood pressure in spontaneously hypertensive rats by targeting eNOS","volume":"47","author":"Shi","year":"2019","journal-title":"Am. J. Chin. Med."},{"issue":"10393","key":"10.1016\/j.phymed.2025.157315_bib0023","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","article-title":"Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59\u2009124 patients","volume":"401","author":"Staplin","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.phymed.2025.157315_bib0024","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/HJH.0000000000001787","article-title":"Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials","volume":"36","author":"Thomopoulos","year":"2018","journal-title":"J. Hypertens."},{"issue":"12","key":"10.1016\/j.phymed.2025.157315_bib0025","article-title":"Chinese guidelines for blood pressure measurement","volume":"19","author":"Wang","year":"2011","journal-title":"Chin J Hypertens"},{"issue":"19","key":"10.1016\/j.phymed.2025.157315_bib0026","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.phymed.2025.157315_bib0027","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/HYPERTENSIONAHA.124.23597","article-title":"Optimal antihypertensive systolic blood pressure: a systematic review and meta-analysis","volume":"81","author":"Whelton","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.phymed.2025.157315_bib0028","first-page":"1","year":"2021","journal-title":"Guideline For the Pharmacological Treatment of Hypertension in Adults"},{"issue":"07","key":"10.1016\/j.phymed.2025.157315_bib35","first-page":"603","article-title":"Chinese guidelines for the management of hypertension (2024 Edition)","volume":"32","year":"2024","journal-title":"Chin J Hypertens"},{"issue":"1","key":"10.1016\/j.phymed.2025.157315_bib0030","first-page":"10","article-title":"Chinese guidelines for the primary management of hypertension (2014 Edition)","volume":"23","year":"2015","journal-title":"Chin J Hypertens"},{"issue":"5","key":"10.1016\/j.phymed.2025.157315_bib0031","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2019.9811","article-title":"Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes","volume":"322","author":"Yang","year":"2019","journal-title":"JAMa"},{"issue":"4","key":"10.1016\/j.phymed.2025.157315_bib0032","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11655-014-1709-6","article-title":"Songling Xuemaikang Capsule for primary hypertension: a systematic review of randomized controlled trials","volume":"21","author":"Yang","year":"2015","journal-title":"Chin. J. Integr. Med."},{"issue":"14","key":"10.1016\/j.phymed.2025.157315_bib0033","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2025.157315_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.771793","article-title":"Effects of Puerarin on the prevention and treatment of cardiovascular diseases","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325009535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325009535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:20:54Z","timestamp":1773152454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325009535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"alternative-id":["S0944711325009535"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157315","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Songling Xuemaikang capsule for grade 1 hypertension at low-to-moderate risk: a multicenter randomized placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"157315"}}